Pensions & Investments Logo
ETF Exchange > XBI ETF

XBI - ETF Fact Sheet

State Street SPDR S&P Biotech ETF - USD

Fund Identification

Ticker

XBI

ISIN

US78464A8707

Main Metrics

Price

$163.38

Expense Ratio

0.35%

AuM

$11,465.14M

Tracking Difference

-0.33%

Ratings

Trackinsight rating

Official Investment Strategy

The SPDR® S&P® Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Biotechnology Select IndustryTM Index. The S&P Biotechnology Select IndustryTM Index represents the biotechnology sub-industry portion of the S&P Total Markets IndexTM. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ® National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

XBI's historical prices, performance, and flows

051015%
1m returns
11%
1m flows
$773M
* Net total returns
All data as of 1 September 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all XBI data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

XBI's characteristics

Manager statistics

382 funds, $2,330.23Bn in AUM

Benchmark

S&P Biotechnology Select Industry Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
XBI's exposure

Countries

USA
95.23%

Sectors

Healthcare
99.35%

Top 5 holdings

Apogee Therapeutics, Inc.
1.65%
Oruka Therapeutics, Inc.
1.53%
Dianthus Therapeutics, Inc.
1.42%
Erasca, Inc.
1.38%
Twist Bioscience Corp.
1.37%
Total holdings
147
Total weight of top 5
7.35%

ETF Education Center

15%